Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level
NCT ID: NCT00815230
Last Updated: 2009-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
20 participants
OBSERVATIONAL
2009-01-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study subjects will be OPD patients who are arranged for cardiac CTA examination because of suspect coronary artery disease (CAD). In total, twenty cases will be enrolled for the study. The formal consent will be delivered and explained to the patients and families after the arrangement of cardiac CTA. It then will be retrieved just before the performance of cardiac CTA.
For each enrolled case, peripheral blood will be sampled three times (once before and twice after the performance of cardiac CTA). Totally 60 blood samples will be collected from 20 study subjects within 3 months (January 1 \~ March 31, 2009). ROS level in the collected blood samples will be then measured, compared, and analyzed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abdominal Computed Tomography and the Blood Reactive Oxygen Species Level
NCT00745641
The Best Parameters for Imaging Agent Injection and Scanning Methods in Computed Tomography Angiography
NCT04832633
320-slice Coronary Computed Tomography (CT) Angiography
NCT00721851
Computed Tomography Versus Exercise Testing in Suspected Coronary Artery Disease
NCT01393028
Computed Tomography Coronary Angiography (CTCA) and Coronary Flow in Stenosis Analysis
NCT00921440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NTUH
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200812057R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.